Cempra Holdings (CEMP) Files $86.5M IPO

October 12, 2011 4:37 PM EDT
Cempra Holdings, LLC (Nasdaq: CEMP) filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. Te proposed maximum offering price is $86.5 million. Cempra plans to list on the Nasdaq Global Market under the ticker "CEMP."

The offering is being made through Stifel Nicolaus Weisel, Leerink Swann, Cowen and Company, and Needham & Company, LLC.

Cempra is a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical unmet medical needs in the treatment of bacterial infectious diseases, particularly respiratory tract infections and skin and skin structure infections.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Stifel, Needham & Company, Cowen & Co

Add Your Comment